Education
About Us
Working with TipRanks
Follow Us
AEON Biopharma (AEON)
:AEON
AEON Stock Chart & Stats
$0.79
-$0.02(-9.37%)
At close: 4:00 PM EST
$0.79
-$0.02(-9.37%)
Day’s Range― - ―
52-Week Range$0.38 - $64.80
Previous CloseN/A
Volume17.80M
Average Volume (3M)273.24K
Market Cap
$11.05M
Enterprise Value$16.43M
Total Cash (Recent Filing)$5.93M
Total Debt (Recent Filing)$18.25M
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Apr 01, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding11,643,786
10 Day Avg. Volume605,674
30 Day Avg. Volume273,237
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.74
Price to Sales (P/S)0.00
P/FCF Ratio-1.04
Enterprise Value/Market Cap1.49
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost ManagementR&D expenses declined 50.8% YoY to $4.4M, which were below the estimate, indicating effective cost management.
Regulatory ApprovalAeon finds alignment with the FDA on key biosimilar pathway requirements, boosting confidence in potential regulatory approval.
Bears Say
Funding UncertaintyGiven the uncertainty in funding, the price target is adjusted to $5 from $6, reflecting potential financial challenges.
Production DependencyAeon relies on Daewoong to manufacture ABP-450, and any production issues with Daewoong could adversely impact Aeon.
AEON Biopharma News
AEON FAQ
What was AEON Biopharma’s price range in the past 12 months?
AEON Biopharma lowest stock price was $0.38 and its highest was $64.80 in the past 12 months.
What is AEON Biopharma’s market cap?
AEON Biopharma’s market cap is $11.05M.
When is AEON Biopharma’s upcoming earnings report date?
AEON Biopharma’s upcoming earnings report date is Apr 01, 2026 which is in 118 days.
How were AEON Biopharma’s earnings last quarter?
AEON Biopharma released its earnings results on Nov 14, 2025. The company reported -$0.39 earnings per share for the quarter, beating the consensus estimate of -$0.43 by $0.04.
Is AEON Biopharma overvalued?
According to Wall Street analysts AEON Biopharma’s price is currently Overvalued.
Does AEON Biopharma pay dividends?
AEON Biopharma does not currently pay dividends.
What is AEON Biopharma’s EPS estimate?
AEON Biopharma’s EPS estimate is -0.13.
How many shares outstanding does AEON Biopharma have?
AEON Biopharma has 11,643,786 shares outstanding.
What happened to AEON Biopharma’s price movement after its last earnings report?
AEON Biopharma reported an EPS of -$0.39 in its last earnings report, beating expectations of -$0.43. Following the earnings report the stock price went down -4.255%.
Which hedge fund is a major shareholder of AEON Biopharma?
Currently, no hedge funds are holding shares in AEON
Company Description
AEON Biopharma
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Technical Analysis
Imunon
―
XTL Biopharmaceuticals Sponsored ADR
―
Aptorum Group
―
Galecto
―
TransCode Therapeutics
―
Ownership Overview
15.33% Insiders
0.30% Mutual Funds
10.01% Other Institutional Investors
73.59% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---